does glp-1 cause cancer Glucagon-like peptide-1 medicines and Potential Use of GLP-1 and

The concept of microdosing reportedly dates back to the 90s, when it was part of clinical drug development, before it was adopted by psychedelics users (and then GLP-1 users)

Regarding acute pancreatitis , there is evidence of a small increased risk, though the magnitude varies across studies

Whilst mild, transient tiredness during the initial weeks of GLP-1 treatment may be expected as your body adjusts, certain situations warrant prompt medical review

doi: 10.1056/NEJMoa1504720 4 NealBPerkovicVMahaffeyKWde ZeeuwDFulcherGEronduNet al

She spoke to a woman who could only take the drug for four months after which excessive nausea and vomiting landed her in the emergency room, compelling her to stop taking the GLP-1 drug that she did not mention by name

* Cardiorenal Protection: SGLT2 inhibitors and GLP-1 agonists are now strongly recommended for high-risk patients regardless of their current A1c level